Finegold, Milton
Baylor College of Medicine
25 papers on CoChatORCID 0000-0002-2153-500X
Most cited papers
- Verified
Purified hematopoietic stem cells can differentiate into hepatocytes in vivo
Lagasse, E., Connors, H., Al-Dhalimy, M., Reitsma, M., Dohse, M., Osborne, L., Wang, X., Finegold, M., Weissman, I. L., & Grompe, M. (2000) · Nature Medicine
Mesenchymal stem cell researchHematopoietic Stem Cell Transplantation
Cited by 2,314
- Verified
In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration
Huch, M., Dorrell, C., Boj, S. F., van Es, J. H., Li, V. S. W., van de Wetering, M., Sato, T., Hamer, K., Sasaki, N., Finegold, M. J., et al. (2013) · Nature
Liver physiology and pathologyWnt/β-catenin signaling in development and cancer
Cited by 1,555
- Verified
Impaired Energy Homeostasis in C/EBPα Knockout Mice
Wang, N.-D., Finegold, M. J., Bradley, A., Ou, C. N., Abdelsayed, S. V., Wilde, M. D., Taylor, L. R., Wilson, D. R., & Darlington, G. J. (1995) · Science
Adipose Tissue and MetabolismMetabolism, Diabetes, and Cancer
Cited by 929
- Verified
Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice
Azuma, H., Paulk, N., Ranade, A., Dorrell, C., Al-Dhalimy, M., Ellis, E., Strom, S., Kay, M. A., Finegold, M., & Grompe, M. (2007) · Nature Biotechnology
Xenotransplantation and immune responseLiver physiology and pathology
Cited by 835
- Verified
Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I
Overturf, K., Al-Dhalimy, M., Tanguay, R., Brantly, M., Ou, C.-N., Finegold, M., & Grompe, M. (1996) · Nature Genetics
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 549
- Verified
Bipotential Adult Liver Progenitors Are Derived from Chronically Injured Mature Hepatocytes
Tarlow, B. D., Pelz, C., Naugler, W. E., Wakefield, L., Wilson, E. M., Finegold, M. J., & Grompe, M. (2014) · Cell Stem Cell
Liver physiology and pathologyMesenchymal stem cell research
Cited by 533
- Verified
The ploidy conveyor of mature hepatocytes as a source of genetic variation
Duncan, A. W., Taylor, M. H., Hickey, R. D., Hanlon Newell, A. E., Lenzi, M. L., Olson, S. B., Finegold, M. J., & Grompe, M. (2010) · Nature
Liver physiology and pathologyMicrotubule and mitosis dynamics
Cited by 525
- Verified
Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis
Kettner, N. M., Voicu, H., Finegold, M. J., Coarfa, C., Sreekumar, A., Putluri, N., Katchy, C. A., Lee, C., Moore, D. D., & Fu, L. (2016) · Cancer Cell
Circadian rhythm and melatoninLiver physiology and pathology
Cited by 508
- Verified
The origin and liver repopulating capacity of murine oval cells
Wang, X., Foster, M., Al-Dhalimy, M., Lagasse, E., Finegold, M., & Grompe, M. (2003) · Proceedings of the National Academy of Sciences
Liver physiology and pathologyMesenchymal stem cell research
Cited by 410
- Verified
Deletion of Ku86 causes early onset of senescence in mice
Vogel, H., Lim, D.-S., Karsenty, G., Finegold, M., & Hasty, P. (1999) · Proceedings of the National Academy of Sciences
Genetics, Aging, and Longevity in Model OrganismsTelomeres, Telomerase, and Senescence
Cited by 368
- Verified
Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice
Grompe, M., al-Dhalimy, M., Finegold, M., Ou, C. N., Burlingame, T., Kennaway, N. G., & Soriano, P. (1993) · Genes & Development
Metabolism and Genetic DisordersAmino Acid Enzymes and Metabolism
Cited by 355
- Verified
Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I
Grompe, M., Lindstedt, S., Al-Dhalimy, M., Kennaway, N. G., Papaconstantinou, J., Torres-Ramos, C. A., Ou, C.-N., & Finegold, M. (1995) · Nature Genetics
Metabolism and Genetic DisordersAmino Acid Enzymes and Metabolism
Cited by 312
- Verified
Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis
Gomez-Ospina, N., Potter, C. J., Xiao, R., Manickam, K., Kim, M.-S., Kim, K. H., Shneider, B. L., Picarsic, J. L., Jacobson, T. A., Zhang, J., et al. (2016) · Nature Communications
Drug Transport and Resistance MechanismsPediatric Hepatobiliary Diseases and Treatments
Cited by 300
- Verified
Bile Acids Activate YAP to Promote Liver Carcinogenesis
Anakk, S., Bhosale, M., Schmidt, V. A., Johnson, R. L., Finegold, M. J., & Moore, D. D. (2013) · Cell Reports
Hippo pathway signaling and YAP/TAZLiver physiology and pathology
Cited by 196
- Verified
Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration
Lu, L., Finegold, M. J., & Johnson, R. L. (2018) · Experimental & Molecular Medicine
Hippo pathway signaling and YAP/TAZLiver physiology and pathology
Cited by 190
- Verified
Telomere Dysfunction Induces Sirtuin Repression that Drives Telomere-Dependent Disease
Amano, H., Chaudhury, A., Rodriguez-Aguayo, C., Lu, L., Akhanov, V., Catic, A., Popov, Y. V., Verdin, E., Johnson, H., Stossi, F., et al. (2019) · Cell Metabolism
Sirtuins and Resveratrol in MedicineTelomeres, Telomerase, and Senescence
Cited by 182
- Verified
Mutations in Bile Salt Export Pump (ABCB11) in Two Children with Progressive Familial Intrahepatic Cholestasis and Cholangiocarcinoma
Scheimann, A. O., Strautnieks, S. S., Knisely, A. S., Byrne, J. A., Thompson, R. J., & Finegold, M. J. (2007) · The Journal of Pediatrics
Pediatric Hepatobiliary Diseases and TreatmentsCholangiocarcinoma and Gallbladder Cancer Studies
Cited by 138
- Verified
Adeno‐associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo†‡
Paulk, N. K., Wursthorn, K., Wang, Z., Finegold, M. J., Kay, M. A., & Grompe, M. (2010) · Hepatology
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 135
- Verified
Activating CAR and β-catenin induces uncontrolled liver growth and tumorigenesis
Dong, B., Lee, J.-S., Park, Y.-Y., Yang, F., Xu, G., Huang, W., Finegold, M. J., & Moore, D. D. (2015) · Nature Communications
Wnt/β-catenin signaling in development and cancerLiver physiology and pathology
Cited by 97
- Verified
Long‐term therapy with NTBC and tyrosine‐restricted diet in a murine model of hereditary tyrosinemia type I
Al-Dhalimy, M., Overturf, K., Finegold, M., & Grompe, M. (2002) · Molecular Genetics and Metabolism
Metabolism and Genetic DisordersAmino Acid Enzymes and Metabolism
Cited by 86
- Verified
Helper‐independent and AAV‐ITR‐independent chromosomal integration of double‐stranded linear DNA vectors in mice
Nakai, H., Montini, E., Fuess, S., Storm, T. A., Meuse, L., Finegold, M., Grompe, M., & Kay, M. A. (2003) · Molecular Therapy
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 52
- Verified
AAV vectors containing rDNA homology display increased chromosomal integration and transgene persistence
Wang, Z., Lisowski, L., Finegold, M. J., Nakai, H., Kay, M. A., & Grompe, M. (2012) · Molecular Therapy
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 44
- Verified
Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah−/− knockout mice model
Orejuela, D., Jorquera, R., Bergeron, A., Finegold, M. J., & Tanguay, R. M. (2008) · Journal of Hepatology
Metabolism and Genetic DisordersAmino Acid Enzymes and Metabolism
Cited by 34
- Verified
Therapeutic Liver Reconstitution With Murine Cells Isolated Long After Death
Erker, L., Azuma, H., Lee, A. Y., Guo, C., Orloff, S., Eaton, L., Benedetti, E., Jensen, B., Finegold, M., Willenbring, H., et al. (2010) · Gastroenterology
Organ Transplantation Techniques and OutcomesLiver physiology and pathology
Cited by 34
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free